Assessing the COVID-19 Outbreak Jan 31

To understand the impact of the COVID-19 outbreak in China and its spread to other parts of the world, GLG recently sat down with Dr. Stephen S. Morse, Professor of Epidemiology at the Mailman School of Public Health of Columbia University. In 2014, the United States Secretary of the Department of Health and Human Services […]

COVID-19: What We Know So Far Jan 28

GLG’s VP & Content Team Lead for Healthcare, Michael Weissman, sat down with Dr. Stephen Ostroff on January 28, 2020 to discuss the COVID-19. We discussed his insights into what we know so far about the virus, its current spread, and what we might be able to infer going forward. Dr. Ostroff was previously Deputy […]

How Speaker Pelosi’s Drug Bill May Impact the Price of Drugs

A bill crafted by House Speaker Nancy Pelosi intended to reduce drug prices will make its way to the House floor after the House Ways and Means Committee approved it on Sept. 22. H.R.3 – Lower Drug Costs Now Act of 2019 would permit The Centers for Medicare and Medicaid Services (CMS), an agency within the U.S. Department […]

Are You Running the Right Survey for the Wrong Reason?

The goal of a survey is to objectively test a hypothesis. Don’t allow bias to creep into your surveys, either in your design or in your respondent pool. You’ve decided to run a survey and you’ve brushed up on the best practices for survey design. Now you must answer the single most important question of this entire process: […]

AI Converges on Life Science

How Will It Help Medical Professionals of the Future? This post is the first in a series about the impact of Artificial Intelligence is having in our world. For each, we asked a GLG Network Member to share insight from their unique perspective. Here, Matthew Lungren, MD MPH, Associate Director of the Stanford Center for […]

The Evolution of Pharmacies

A lot has changed since a pharmacy was just a place to pick up prescriptions. Bob Zimmerman, former SVP of Corporate Development and Chief Strategy Officer at Walgreens, tells us that big name traditional drug stores like Walgreens, CVS, and Rite Aid, have made themselves so convenient and accessible that they have bifurcated the shopping […]

Addressing the Question of Who Should Pay the High Costs of Drugs

Former Pfizer Chairman and CEO Jeff Kindler shares how the pharmaceutical industry is a “very unusual and unique business.” He discusses the increasing challenges of the various stages of drug discovery, drug development, registration and marketing. Kindler also stresses the impact mentors have had on his career as an executive. Jeff Kindler is the former […]

Precision Medicine in Childhood Cancer Treatments

Dr. Andrew Kung shares about his team’s focus, the clinical implementation of sequencing precision medicine, and how they tailor treatment plans to support children and their families during all stages of the treatment process. Andrew Kung, MD, PhD, is Chief of Pediatric Hematology, Oncology, and Stem Cell Transplantation at Columbia University. His clinical expertise is […]

The Process of Identifying Opportunities for Innovation

The key to successful innovation is developing processes that uncover a company’s key competencies and then using those competencies to form innovative solutions through workforce development. Gottfried Dutine, Chief Innovation Officer at Royal Philips, shares how Philips used this process to enhance medical image processing used by pathologists to diagnose medical conditions. Gottfried H. Dutine […]

The Rise of Specialty Pharmacy

Pharmacy benefit managers (PBMs) traditionally determine two things facing American taxpayers: the affordability and accessibility of drugs. According to industry expert Albert Thigpen, the scope of PBM’s influence is shrinking as the federal government solidifies its place as the largest single payer of prescription drugs. Thigpen is hopeful, however, that the rise of specialty pharmacy […]

Evaluating Best Practices in Medical Device Reprocessing to Improve Public Health

Larry Kessler, ScD, is a Professor in the Department of Health Services at the University of Washington School of Public Health. Previously, he spent over 13 years at the FDA, most recently from 2002-2009, as Director of the Office of Science and Engineering Laboratories (OSEL) at the Center for Devices and Radiological Health (CDRH). In […]

Personalized Care for Crohn’s Disease Patients

Gastroenterologist Robert Burakoff discusses how personalized treatment for Crohn’s disease and other chronic inflammatory diseases can improve the lives of patients. He shares how personalized treatment impacts the pharmaceutical industry and why it is the most promising approach. Robert Burakoff MD, MPH is a Clinical Chief of the Division of Gastroenterology and Director of the […]

Speaker Biographies

Hilary Malone PhD, has over 25 years of experience in global drug development, regulatory &government affairs, manufacturing and commercialization within the biopharma industry. Hilary hassignificant board level and executive committee experience including large scale organizationalrestructuring/transformation/integration, major M&A, biotech start-up, capital raising, investorrelations and pre-IPO.​

Hilary is currently CEO of Stylus Medicine, a private genetic medicine biotech company. Previously sheserved as CEO of a Series-A neuroscience company. Prior to these roles, Hilary served as COO & EVP atValo Health Inc., Chief Regulatory Officer & SVP at Sanofi Inc., and Chief Regulatory Officer & SVP atPfizer and Wyeth. Previous experience also includes senior regulatory and drug development roles atReata Pharmaceuticals Inc., AstraZeneca plc and GlaxoSmithKline plc.​

Hilary also serves on the Board of Directors of Hansa Biopharma and Adthera Bio. Hilary holds a PhD inMolecular Neuropharmacology and a BSc in Physiology.

Dr. Thomas Lönngren is Director at his own company PharmaExec Consulting AB. He is the Chairman of the Board of directors at Egetis Therapeutics AB, Sweden. Dr Lönngren also serves as board member at Compass Pathways PLC, London UK and NDA Group, Sweden. He acts as advisor to the following companies and organizations: NDA group, Sweden, Sweden, Artis Venture, San Francisco, US, Fujimoto Japan, Skin2Neuron Pty Ltd, Sydney, Australia, US, Special advisor to the Centre for Innovation in Regulatory Science (CIRS), London UK. From 2001 until2011, Mr.Lönngren served as the Executive Director of the European Medical Agency. He was previously Deputy General Director of the Swedish Medical Product Agency until 2000. He has a degree in pharmacy and MSc in Social and Regulatory Pharmacy from Uppsala University. He is also an Honorary Member of the Royal Pharmaceutical Society of Great Britain, Honorary Fellow of the Royal College of Physicians in Great Britain, Honorary Doctorate from the University of Uppsala, Honorary Doctorate from University of Bath, UK.

Speaker Biographies

Marie-Anne Aymerich

Marie-Anne has built a portfolio of senior advisory and non-executive roles, following a successful international career in the FMCG and Luxury sectors. She is a non-executive director of Haleon, a FTSE100 company listed in 2022 after the demerger from GSK. She is also chairwoman of Haleon Environment and Societal Sustainability committee. She is the executive director of the Pierre Fabre Group where she also sits on the Strategic Committee, and she is a Board Member of The Academy of St. Martin-in-the-Fields, one of the world’s most prestigious chamber orchestras. She is also an angel investor and focuses her time and investments on start-ups with the strongest purpose and impact.

Marie-Anne is also a regular lecturer at HEC Paris on purposeful leadership, and she has created a serious game called “Planet Purpose” to upskill people on sustainability and purpose. Throughout her 35year executive career she delivered a strong track-record of business performance and growth in brands and portfolio in both developed and emerging economies.

As a senior leader with Unilever, she led a number of different personal care categories across France, Spain and the USA – including managing the Dove brand worldwide and culminating in leading Unilever’s global Oral Care division. She also worked for LVMH as Brand General Manager of Dior Perfumes and Cosmetics worldwide. Marie-Anne was also Vice-President of Imagine for Margo – Children with Cancer for ten years, a charity she helped found in 2011 with the goal of eradicating children’s cancer. The charity is the #1 charity focused on child cancer in France and has fundraised more than €14m since its creation. Marie-Anne is a graduate from HEC Paris. She is married and has two children aged 29 and 26.

Patrick Jephson

Patrick Jephson is a consultant, journalist, broadcaster and New York Times bestselling author, based in Washington D.C. He is a published authority on corporate and personal branding and crisis communications, addressing conferences worldwide as well as events at the U.S. State Department, the American University and the Annenberg School for Communication and Journalism.

With more than twenty-five years’ experience in the government, luxury and family office sectors, Patrick’s portfolio has included globally admired brands as well as national agencies and NGOs. He has also worked on reputation and legacy briefs with European, Middle Eastern and Asian families, including royalty. He now writes, presents, and advises on factual and drama TV programs, appearing on every major American and many international networks. He was recently an expert consultant to the award-winning Netflix series The Crown and provided live commentary on the Coronation of King Charles.

Patrick owes much of his practical communications and protocol experience to Princess Diana, who chose him to be her equerry and only private secretary/chief of staff. He served the Princess for eight years, responsible for all aspects of her public life, global humanitarian initiatives, and private organization. Having worked for an internationally high-profile woman (and as the father of two professionally successful daughters) he feels a special affinity for cross-cultural, gender and perception issues.

Patrick was born and raised in Ireland and holds a master’s degree in political science from Cambridge University. As an officer in the British Royal Navy, he served all over the world before being selected for royal duty. He is a citizen of the U.K., U.S.A., Ireland, and Canada.